Rankings
▼
Calendar
RAPP (Rapport Therapeutics, Inc. Common Stock) Stock Financials & Earnings | Market Cap Arena
RAPP
Rapport Therapeutics, Inc. Common Stock
Mkt Cap
$1B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$111M
EPS (TTM)
-$2.30
Free Cash Flow (TTM)
-$88M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
-$15K
-$5M
Q2 23
$0
-$21K
-$7M
Q3 23
$0
$0
-$10M
Q4 23
$0
-$76K
-$15M
Q1 24
$0
-$152K
-$17M
Q2 24
$0
-$208K
-$21M
Q3 24
$0
$0
-$22M
Q4 24
$0
$0
-$24M
Q1 25
$0
$0
-$27M
Q2 25
$0
$0
-$29M
Q3 25
$0
$0
-$30M
Q4 25
$0
$0
-$39M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$5M
-$5M
Q2 23
-$7M
-$7M
Q3 23
-$5M
-$5M
Q4 23
-$10M
-$12M
Q1 24
-$18M
-$19M
Q2 24
-$16M
-$17M
Q3 24
-$16M
-$17M
Q4 24
-$14M
-$15M
Q1 25
-$20M
-$21M
Q2 25
-$25M
-$25M
Q3 25
-$17M
-$18M
Q4 25
-$25M
-$25M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$61K
Q2 23
$86K
Q3 23
$52K
Q4 23
$1M
Q1 24
$1M
Q2 24
$967K
Q3 24
$140K
Q4 24
$226K
Q1 25
$291K
Q2 25
$22K
Q3 25
$134K
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 24
—
+229.3%
Q2 24
—
+213.7%
Q3 24
—
+126.3%
Q4 24
—
+59.0%
Q1 25
—
+58.6%
Q2 25
—
+41.8%
Q3 25
—
+38.6%
Q4 25
—
+63.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$723K
—
Q2 23
$945K
—
Q3 23
$859K
—
Q4 23
$998K
—
Q1 24
$1M
—
Q2 24
$2M
—
Q3 24
$3M
—
Q4 24
$3M
—
Q1 25
$4M
—
Q2 25
$4M
—
Q3 25
$5M
—
Q4 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$4M
$1M
Q2 23
$5M
$2M
Q3 23
$8M
$2M
Q4 23
$12M
$3M
Q1 24
$13M
$5M
Q2 24
$16M
$5M
Q3 24
$16M
$6M
Q4 24
$17M
$6M
Q1 25
$20M
$8M
Q2 25
$23M
$7M
Q3 25
$22M
$8M
Q4 25
$30M
$8M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 23
$70M
$77M
$147M
Q1 24
$74M
$119M
$193M
Q2 24
$110M
$226M
$336M
Q3 24
$39M
$281M
$321M
Q4 24
$57M
$248M
$305M
Q1 25
$58M
$228M
$285M
Q2 25
$55M
$205M
$260M
Q3 25
$251M
$262M
$513M
Q4 25
$53M
$438M
$491M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
19M
—
Q2 23
20M
+3.4%
Q3 23
19M
-5.1%
Q4 23
18M
-5.3%
Q1 24
19M
+7.6%
Q2 24
20M
+3.4%
Q3 24
19M
-4.7%
Q4 24
19M
+0.6%
Q1 25
19M
+0.0%
Q2 25
35M
+83.8%
Q3 25
38M
+7.0%
Q4 25
47M
+23.9%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 22
—
—
FY 23
—
—
FY 24
$0
69
FY 25
$0
84
marketcaparena.com